KOS PHARMACEUTICALS INC
10-Q/A, EX-27, 2000-08-10
PHARMACEUTICAL PREPARATIONS
Previous: KOS PHARMACEUTICALS INC, 10-Q/A, EX-10.2, 2000-08-10
Next: UNITED AUTO GROUP INC, 10-Q, 2000-08-10



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM KOS
PHARMACEUTICALS, INC.'S FORM 10-Q FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2000,
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           3,929
<SECURITIES>                                         0
<RECEIVABLES>                                    5,771
<ALLOWANCES>                                     (257)
<INVENTORY>                                      1,591
<CURRENT-ASSETS>                                13,962
<PP&E>                                          18,562
<DEPRECIATION>                                 (9,305)
<TOTAL-ASSETS>                                  24,045
<CURRENT-LIABILITIES>                           15,415
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           197
<OTHER-SE>                                    (54,592)
<TOTAL-LIABILITY-AND-EQUITY>                    24,045
<SALES>                                          9,122
<TOTAL-REVENUES>                                10,159
<CGS>                                            1,131
<TOTAL-COSTS>                                   20,758
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,671
<INCOME-PRETAX>                               (12,270)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (12,270)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (12,270)
<EPS-BASIC>                                     (0.65)
<EPS-DILUTED>                                   (0.65)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission